HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Combination Therapy of Carnosic Acid and Methotrexate Effectively Suppressed the Inflammatory Markers and Oxidative Stress in Experimental Arthritis.

AbstractBACKGROUND:
Combination therapy with methotrexate (MTX) is the most common therapeutic strategy used for the treatment of patients with rheumatoid arthritis (RA). In this study, we combined the natural compound carnosic acid (CA) with MTX to reduce inflammation and oxidative stress in adjuvant arthritis (AA).
METHODS:
AA was induced in 6-8 rats per group. MTX was administrated twice a week at a dose of 0.3 mg/kg b.w., while CA was administered daily at a dose of 100 mg/kg both in monotherapy and in combination with MTX. Plasma samples were collected on the 14th, 21st, and 28th day. Body weight and hind paw volume were measured once a week.
RESULTS:
We found that, mainly, the CA + MTX combination significantly reduced the hind paw swelling, the levels of IL-17A, MMP-9, and MCP-1 in plasma, and GGT activity in joint homogenates. The mRNA expression of HO-1, catalase, and IL-1β in the liver were significantly improved by CA + MTX only. Our results indicate that adding CA to MTX treatment could be a good therapeutic option for patients suffering from RA.
CONCLUSIONS:
The addition of CA to methotrexate treatment significantly improved its efficacy in decreasing the development of AA by inhibiting the markers of inflammation and oxidative stress.
AuthorsMartin Chrastina, Silvester Poništ, Jaroslav Tóth, Szilvia Czigle, Ľudmila Pašková, Veronika Vyletelová, Karol Švík, Katarína Bauerová
JournalMolecules (Basel, Switzerland) (Molecules) Vol. 27 Issue 20 (Oct 21 2022) ISSN: 1420-3049 [Electronic] Switzerland
PMID36296709 (Publication Type: Journal Article)
Chemical References
  • Methotrexate
  • Interleukin-17
  • Matrix Metalloproteinase 9
  • salvin
  • Catalase
  • Biomarkers
  • RNA, Messenger
Topics
  • Rats
  • Animals
  • Methotrexate
  • Arthritis, Experimental (drug therapy)
  • Interleukin-17 (metabolism)
  • Matrix Metalloproteinase 9 (metabolism)
  • Catalase (metabolism)
  • Drug Therapy, Combination
  • Arthritis, Rheumatoid (drug therapy)
  • Oxidative Stress
  • Biomarkers (metabolism)
  • Inflammation (drug therapy, metabolism)
  • RNA, Messenger (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: